Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes (Q34153553)

31 July 2017

Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes (English)

1 reference

31 July 2017

1 reference

1 reference

4

Boguslaw Okopien

1 reference

31 July 2017

1

Robert Krysiak

1 reference

31 July 2017

2

Anna Gdula-Dymek

1 reference

31 July 2017

3

Ryszard Bachowski

1 reference

PubMed ID

20587704

31 July 2017

language of work or name

English

0 references

publication date

29 June 2010

1 reference

31 July 2017

1 reference

31 July 2017

33

1 reference

31 July 2017

2266-2270

1 reference

31 July 2017

10

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

31 July 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Pleiotropic effects of statins--clinical evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Cytokines in atherosclerosis: pathogenic and regulatory pathways

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945172

Extralipid effects of micronized fenofibrate in dyslipidemic patients

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20587704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC10-0272

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

20587704